Adding antioxidants to anti-malarial treatment may prevent learning impairment
June 26th, 2010 - 2:01 pm ICT by ANIWashington, June 26 (ANI): Scientists have discovered that adding antioxidant therapy to traditional anti-malarial treatment may prevent long-lasting cognitive impairment in cerebral malaria.
Recent studies of children with cerebral malaria indicate that cognitive deficits, which may impair memory, learning, language, and mathematical abilities, persist in many survivors even after the infection itself is cured.
“This complication may impose an enormous social and economic burden because of the number of people at risk for severe malaria worldwide,” says Guy A. Zimmerman professor and associate chair for research in the University of Utah School of Medicine’s Department of Internal Medicine.
Zimmerman and colleagues in Brazil found similarities in persistence of cognitive damage in mice with documented cerebral malaria after cure of the acute parasitic disease with chloroquine- an antimalarial therapy, and children who survived the infection.
The team found high oxidative stress in mice with cerebral malaria and also found that treating them with and two antioxidant agents, desferoxamine and N-acetylcysteine prevented both inflammatory and vascular changes in the tissues of the brain, as well as the development of persistent cognitive damage.
“Our findings are exciting because the clinical implications may not be limited to cerebral malaria,” says Zimmerman.
Antioxidant treatment could be vital in treating other types of severe infection and in chronic non-infectious conditions such as neurodegenerative diseases too, he added.
Their findings were published online June 24, 2010, in the journal PLoS Pathogens. (ANI)
- Natural compounds could pave way for novel anti-malaria drugs - Mar 15, 2011
- New class of compounds to combat malaria - Nov 20, 2011
- East Africa's antimalarial trees at risk of extinction - Apr 21, 2011
- Resistance to malaria drug rings alarm bells - Apr 08, 2012
- EPO doping 'can cut cerebral malaria related deaths' - Apr 22, 2011
- Coming soon: Single-dose malaria drug - Sep 04, 2010
- Novel anti-malarial drug candidate found - May 26, 2010
- Indications of Alzheimer's may be evident decades before first signs - Mar 29, 2011
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- Ineffective monotherapies dominating high-burden malarious countries - Nov 02, 2009
- Brain scans may predict future Alzheimer's patients - Apr 07, 2011
- Community-based treatment of malaria, pneumonia could save lives: Study - Sep 22, 2010
- Blood-thinning drug can stop malaria infection - Jun 02, 2010
- Scientists reverse loss of smell in early Alzheimer's - Dec 01, 2011
- New gene study paves way for more anti-malaria treatments - Oct 11, 2010
Tags: associate chair, cerebral malaria, chloroquine, clinical implications, cognitive deficits, cognitive impairment, economic burden, infectious conditions, internal medicine, learning language, mathematical abilities, n acetylcysteine, neurodegenerative diseases, oxidative stress, parasitic disease, school of medicine, university of utah school of medicine, utah school, vascular changes, zimmerman